UPDATE: Raymond James Resumes ZIOPHARM Oncology (ZIOP) at Outperform
Tweet Send to a Friend
(Updated - August 22, 2019 4:28 PM EDT)
Raymond James analyst David Novak resumes coverage on ZIOPHARM Oncology (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst David Novak resumes coverage on ZIOPHARM Oncology (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
